RegCell: Funding, Investors & Team (Oct 2026)
RegCell develops cell therapies designed to restore immune tolerance in autoimmune diseases.
RegCell has raised $44.0M across 1 funding round on record, the most recent a Series A of $44.0M announced in Sep 2026.
That round is above the $7.5M median round size for United States companies tracked on FundedIQ over the last two years.
RegCell Company Profile and Key Stats
Latest funding round on record: Sep 2026.
RegCell Funding Rounds
RegCell Investors
21 investors are recorded in total; the 5 named above are those the record identifies.
RegCell Funding in Context
RegCell's latest round of $44.0M is above the median round in United States. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like RegCell in Biopharma and Emeryville
Companies Similar to RegCell
Maxwell Power is a renewable energy company that installs solar panels.
Biotia is a health tech company spun out of Cornell Tech leveraging next-generation sequencing and artificial…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Parakeet Health is an AI patient engagement platform that helps healthcare organizations improve the patient…
Walapay is an API platform connecting stablecoins and banks for global business payouts.
doxx.net is a parallel, sovereign internet infrastructure designed to provide data security and privacy for…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Armadin develops an AI-native cybersecurity platform that helps organizations identify and validate…
Halluminate develops benchmarks and reinforcement-learning environments for evaluating AI systems on…
Daptic develops regulatory intelligence software that helps companies track, analyze, and manage global…
Satlyt develops software infrastructure for in-orbit computing that enables satellites to process data…
GTM on autopilot. Revnu runs your pipeline, ads and growth.
RegCell Funding FAQs
What does RegCell do?
RegCell develops cell therapies designed to restore immune tolerance in autoimmune diseases.
How much funding has RegCell raised?
RegCell has raised $44.0M across 1 round on record. The most recent is a Series A of $44.0M announced in Sep 2026.
When did RegCell last raise funding?
RegCell's most recent funding round on record is a Series A of $44.0M, announced in Sep 2026.
Who has invested in RegCell?
Investors on record for RegCell include Alumni Ventures, Mitsubishi UFJ Capital, Playground Global, Global Brain Corporation, UTEC - The University of Tokyo Edge Capital Partners. FundedIQ records 21 investors in total.
Where is RegCell headquartered?
RegCell is based in Emeryville, United States.
How many employees does RegCell have?
RegCell is in the 1-10 employee band.
When was RegCell founded?
RegCell was founded in 2016.
About FundedIQ's RegCell Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for RegCell is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.